I am a long investor and I am buying more this week. It is to bad that all the bashers are small(short) people. This could be a great company with many good products. Their relationship with ANP.AX who is doing the study is good. Maybe it is time that all the little people(short) quit crying and get out or get on.BUY BUY BUY Karl
Well here we are 3 weeks later and low and behold this co that a lot of little (short) were trying to bash, seems to be heading inthe right direction. As I said before, this is a good co with many good products. I bought more before and I will buy more now. BUY BUY I am looking for some help on a good investment in Micro Islets dealing with diabetes and insulin. Any help will be appreciated. K
I too have been a long investor for some time. As I see it ISIS, like most biotech companies are run by management that seems to focus more on the science and less on the PR hype that tend to drive the stock. It is my belief that ISIS has the science, the technology but since ISIS is not a household name (yet), like J & J, Amgen, or Genentech, for that matter .... there is no impetus presently to move the stock .... I feel this is about to change, with drugs in late clinicals and TIGER ....... this best kept secret (ISIS) will go from a whisper to a shout very quickly ...... I'm buying more on the dips, good investing to all long ISIS shareholders.
Thankyou for your morning humor. The Crooke has shouted from the roof tops since 1996, "REVOLUTIONARY" "REVOLUTIONARY ISIS ANTISENSE!" as he sold to the naive fund managers millions of shares of Isis paper. The junkyard doggie has hyped this junk at every flea market imaginable. Citigroup & others were taken big time as the Crooke sold his freebie shares to them. Isis is a biotech known throughout Wall Street as a ballyhoo pump hype company. :>( There are money managers that say fool me once shame on you, never again!